Residual Solvent Analysis in Pharmaceuticals

The author discusses the current pharmacopeial status of the acceptance limits and classifications of pharmaceutical residual solvents.

External Link - article-38267.pdf

Articles in this issue

over 23 years ago

Article

Contract Services

over 23 years ago

Article

Major Changes Ahead for FDA

over 23 years ago

Article

Estimation of Distribution Coefficients from the Partition Coefficient and pKa

over 23 years ago

Article

Preparation and In Vitro Evaluation of Miconazole Nitrate-Loaded Topical Liposomes

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Residual Solvent Analysis in Pharmaceuticals

Articles in this issue

Trending on Pharmaceutical Technology

FDA Activity Round Up – July 2026

Midyear 2026 Check-In: AI, Supply Chains, and the NDC-12 Story Nobody's Watching

Can Governance-by-Design Make AI Compliant in Pharma? (Part II)

From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026

Mid-Year Check-In: Are Henrik Johanning's Pharma Manufacturing Predictions Holding Up?